GlobeNewsWire · CLYM · October 24, 2026

Climb Bio Presents Initial PrisMN Phase 2 Data from Budoprutug in pMN at an Oral Session at ASN Kidney Week 2026

Get the app for more

Explore stock news, insights and company research.